ABBV vs NRIX · P/E 81, rev $61.16B vs rev $54.5M
AbbVie Inc (ABBV) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the ABBV and NRIX stock pages for the full models.
Not investment advice.